Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties

81Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Celecoxib spherical agglomerates were prepared with polyvinylpyrrolidone (PVP) using acetone, water and chloroform as solvent, non-solvent and bridging liquid, respectively The agglomerates were characterized by differential scanning calorimetry (DSC), X-ray diffraction (XRD), IR spectroscopic studies and scanning electron microscopy (SEM). The IR spectroscopy and DSC results indicated the absence of any interactions between drug and additives. XRD studies showed a decrease in crystallinity in agglomerates. The crystals exhibited significantly improved micromeritic properties compared to pure drug. The loading efficiency (% or mg drug per 100 mg crystals) was in the range of 93.9 ± 2.3 and 97.3 ± 1.3% (n = 3) with all formulations. The aqueous solubility and dissolution rate of the drug from crystals was significantly (p < 0.05) increased (nearly two times). The solubility and in vitro drug release rates increased with an increase in PVP concentration (from 2.5 to 10%). The SEM studies showed that the crystal posseses a good spherical shape with smooth and regular surface.

Cite

CITATION STYLE

APA

Gupta, V. R., Mutalik, S., Patel, M. M., & Jani, G. K. (2007). Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharmaceutica, 57(2), 173–184. https://doi.org/10.2478/v10007-007-0014-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free